ArticleOpen life sciences2024

Thymosin α1 combined with XELOX improves immune function and reduces serum tumor markers in colorectal cancer patients after radical surgery.

Li Sha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.